Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 544b (MIR544B) is a member of the microRNA precursor family, functioning as a post-transcriptional regulator. It is upregulated in several cancers, including colorectal cancer, where it promotes cell proliferation and invasion by targeting mRNAs such as forkhead box O1 (FOXO1)[1][4]. MIR544B influences cell cycle transition and may serve as an oncogenic miRNA, making it a potential therapeutic target and biomarker in oncology[1]. Experimental modulation of MIR544B (using mimics or inhibitors) is explored in molecular biology and preclinical cancer research[3][4].
Drugs or molecules (such as anti-miRs) inhibit or mimic MIR544B activity, affecting gene regulation (notably, suppression of tumor suppressor genes like FOXO1)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 544b (MIR544B).